Increased apolipoprotein E and c-fms gene expression without elevated interleukin 1 or 6 mRNA levels indicates selective activation of macrophage functions in advanced human atheroma.
Open Access
- 1 April 1992
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 89 (7) , 2814-2818
- https://doi.org/10.1073/pnas.89.7.2814
Abstract
Cells found within atherosclerotic lesions can produce in culture protein mediators that may participate in atherogenesis. To test whether human atheromata actually contain transcripts for certain of these genes, we compared levels of mRNAs in carotid or coronary atheromata and in nonatherosclerotic human vessels by polymerase chain reaction (PCR) amplification of cDNAs reverse-transcribed from RNA. We measured PCR products (generated during exponential amplification) by incorporation of 32P-labeled primers. Levels of interleukin 1 alpha, 1 beta, or 6 mRNAs in plaques and controls did not differ. Compared to uninvolved vessels, plaques did contain higher levels of mRNA encoding platelet-derived growth factor A chain (42 +/- 24 vs. 12 +/- 10 fmol of product; mean +/- SD; n = 8 and 8, respectively; P = 0.007) and B chain (41 +/- 36 vs. 4 +/- 3 fmol of product, n = 14 and 6, respectively; P = 0.024). Atherosclerotic lesions consistently had much higher levels of apolipoprotein E (apoE) mRNA than did control vessels (131 +/- 71 vs. 5 +/- 3 fmol of product; n = 12 and 10, respectively; P less than 0.001). Direct RNA blot analyses confirmed elevated levels of apoE mRNA in plaque extracts. To test whether mononuclear phagocytes might be a source of the apoE mRNA, we studied a selective marker for cells of the monocytic lineage, the c-fms protooncogene, which encodes the receptor for macrophage colony-stimulating factor. Plaques also contained elevated levels of c-fms mRNA (30 +/- 17 vs. 5 +/- 3 fmol of product; n = 10 and 7, respectively; P = 0.002). Immunohistochemical colocalization demonstrated apoE protein in association with macrophages in plaques, whereas nonatherosclerotic vessels showed no immunoreactive apoE. ApoE produced locally in atheroma might modulate the functions of lesional T cells or promote "reverse cholesterol transport" by associating with high density lipoprotein particles, thus targeting them for peripheral uptake. Macrophages within the advanced human atheroma appear to exhibit a selective program of activation as they express high levels of apoE, whereas overall levels of interleukin 1 or 6 mRNAs in plaques are not elevated.Keywords
This publication has 50 references indexed in Scilit:
- Induction of apolipoprotein E gene expression in human and experimental atherosclerotic lesionsBiochemical and Biophysical Research Communications, 1990
- Adult human vascular endothelial cells express the IL6 gene differentially in response to LPS or IL1Cellular Immunology, 1989
- Enhanced apolipoprotein E production with normal hepatic mRNA levels in the Watanabe heritable hyperlipidemic rabbit.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1988
- Expression of apolipoprotein E by cultured vascular smooth muscle cells is controlled by growth state.The Journal of cell biology, 1988
- Production of Platelet-Derived Growth Factor–like Mitogen by Smooth-Muscle Cells from Human AtheromaNew England Journal of Medicine, 1988
- Tumor necrosis factor-mediated release of platelet-derived growth factor from cultured endothelial cells.The Journal of Experimental Medicine, 1987
- A monoclonal antibody against alpha-smooth muscle actin: a new probe for smooth muscle differentiation.The Journal of cell biology, 1986
- Activation of coagulation releases endothelial cell mitogens.The Journal of cell biology, 1986
- Immunohistochemical localization of apolipoprotein E in atherosclerotic lesions of the aorta and coronary arteriesAtherosclerosis, 1986
- The Cell and Molecular Biology of Apolipoprotein E Synthesis by Macro PhagesPublished by Wiley ,1986